Center for Medicare Advocacy

Advancing Access to Medicare and Healthcare

Medicare Part D / Prescription Drugs

Implementation of Medicare Drug Bill Proceeds – This Progress Must be Defended

As discussed in a previous CMA Alert (Aug. 18, 2022), President Biden signed into law the Inflation Reduction Act (IRA) of 2022 on August 16, 2022. This bill includes historic prescription drug provisions that are already providing significant … [Read more...] about Implementation of Medicare Drug Bill Proceeds – This Progress Must be Defended

Center for Medicare Advocacy Comments on Proposed Part C & D Rule

As noted in this December 2022 CMA Alert, CMS released a proposed rule for Medicare Advantage and Part D for 2024 available here (87 Fed Register 79452, December 27, 2022). CMS also published a press release and accompanying fact sheet … [Read more...] about Center for Medicare Advocacy Comments on Proposed Part C & D Rule

Critical Provisions of Medicare Drug Bill Already Taking Effect

As discussed in a recent CMA Alert (Dec. 8, 2022), provisions of the Inflation Reduction Act (IRA) have begun to take effect, and other provisions are soon to follow. However, these historic changes are already being threatened by the pharmaceutical … [Read more...] about Critical Provisions of Medicare Drug Bill Already Taking Effect

CMS Issues Proposed Rules Impacting Medicare Advantage – Part C & D Rule for 2024, and Separate Prior Authorization Rule

As the Center for Medicare Advocacy has long noted, the Medicare Advantage (MA) program is in significant need of heighted regulation and oversight, not just for the sake of the Medicare program’s financial footing, but for the sake of the … [Read more...] about CMS Issues Proposed Rules Impacting Medicare Advantage – Part C & D Rule for 2024, and Separate Prior Authorization Rule

Provisions of Recently Passed Medicare Drug Bill in Effect Next Month – January 2023

As discussed in a recent CMA Alert (Aug. 18, 2022), President Biden signed into law the Inflation Reduction Act (IRA) of 2022 on August 16, 2022. This bill includes historic prescription drug provisions that will soon be of significant benefit to … [Read more...] about Provisions of Recently Passed Medicare Drug Bill in Effect Next Month – January 2023

Center for Medicare Advocacy Sues, Again, for Coverage of “Off-label” Prescription Drug

On November 18, 2022, the Center for Medicare Advocacy and Murphy Orlando LLC filed suit on behalf of a retired public-school teacher in New Jersey who seeks coverage of her “off-label” (non-FDA-approved) use of a critically needed medication. … [Read more...] about Center for Medicare Advocacy Sues, Again, for Coverage of “Off-label” Prescription Drug

President Biden Signs Inflation Reduction Act into Law – Includes Critical Medicare Prescription Drug Provisions

On Tuesday, August 16, 2022, President Biden signed into law the Inflation Reduction Act (IRA) of 2022, which includes expansive health and climate provisions.  This bill is the culmination of over a year of debate about a wide range of … [Read more...] about President Biden Signs Inflation Reduction Act into Law – Includes Critical Medicare Prescription Drug Provisions

Senate Poised to Vote on Important Bill with Valuable Medicare Drug Provisions

The Senate is nearing a vote on the Inflation Reduction Act (IRA) of 2022, a scaled back, but still transformational, reconciliation package that includes critical Medicare prescription drug and Affordable Care Act (ACA) improvements. Among other … [Read more...] about Senate Poised to Vote on Important Bill with Valuable Medicare Drug Provisions

CMS Needs to Rein in Medicare Advantage Overpayments and Heighten Oversight of Insurance Industry

Center Comments Regarding CMS’ Advance Payment Notice and Proposed Part C & D Rule The Center for Medicare Advocacy recently submitted comments to the Centers for Medicare & Medicaid Services (CMS) regarding their Advance payment rule … [Read more...] about CMS Needs to Rein in Medicare Advantage Overpayments and Heighten Oversight of Insurance Industry

Skip to content